Citation Formats
Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. B. FERHANOĞLU Et Al. , "Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey," 22nd Congress of the European Hematolgy Association , 2017

FERHANOĞLU, A. B. Et Al. 2017. Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey. 22nd Congress of the European Hematolgy Association .

FERHANOĞLU, A. B., BEKÖZ, H. S., KARADURMUŞ, N., PAYDAŞ, S., GÜLBAŞ, Z., TÜRKER, A., ... TOPTAŞ, T.(2017). Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey . 22nd Congress of the European Hematolgy Association

FERHANOĞLU, AHMET Et Al. "Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey," 22nd Congress of the European Hematolgy Association, 2017

FERHANOĞLU, AHMET B. Et Al. "Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey." 22nd Congress of the European Hematolgy Association , 2017

FERHANOĞLU, A. B. Et Al. (2017) . "Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey." 22nd Congress of the European Hematolgy Association .

@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey}, congress name={22nd Congress of the European Hematolgy Association}, city={}, country={}, year={2017}}